Bayer’s chief executive said talks with the EU Commission over the antitrust scrutiny of the German drugmaker’s planned takeover of US seeds maker Monsanto were “very good and constructive”, confirming a target to wrap up the deal by year-end.
Bayer still expects to be able to file for regulatory approval in Europe by the end of June, and CEO Werner Baumann reiterated that EU regulators would likely launch an in-depth analysis of the transaction, which will create the world’s largest supplier in the combined seeds and crop chemicals market.
“We are in very good and constructive talks with the EU Commission’s Competition Department. But we are not quite there yet,” Baumann told journalists.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
